Association between genetic polymorphisms of long noncoding RNA H19 and cancer risk: a meta-analysis

Abbastabar M., Sarfi M., Golestani A. and Khalili E. 2018 lncRNA involvement in hepatocellular carcinoma metastasis and prognosis. EXCLI J. 17, 900–913.

Abdollahzadeh S. and Ghorbian S. 2018 Association of the study between LncRNA-H19 gene polymorphisms with the risk of breast cancer. J. Clin. Lab. Anal. 33, e22826.

Barnholtz-Sloan J. S., Shetty P. B., Guan X., Nyante S. J., Luo J., Brennan D. J. et al. 2010 FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African–American and younger women. Carcinogenesis 31, 1417–1423.

Bhatti P., Doody M. M., Alexander B. H., Yuenger J., Simon S. L., Weinstock R. M. et al. 2008 Breast cancer risk polymorphisms and interaction with ionizing radiation among US radiologic technologists. Cancer Epidemiol. Biomark. Prev. 17, 2007–2011.

Bray F., Ferlay J., Soerjomataram I., Siegel R. L., Torre L. A., Jemal A. 2018 Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424.

Butt S., Harlid S., Borgquist S., Ivarsson M., Landberg G., Dillner J. et al. 2012 Genetic predisposition, parity, age at first childbirth and risk for breast cancer. BMC Res. Notes 5, 414.

Cheetham S. W., Gruhl F., Mattick J. S. and Dinger M. E. 2013 Long noncoding RNAs and the genetics of cancer. Br. J. Cancer 108, 2419–2425.

Cui P., Zhao Y., Chu X., He N., Zheng H., Han J. et al. 2018 SNP rs2071095 in LincRNA H19 is associated with breast cancer risk. Breast Cancer Res. Treat. 171, 161–171.

de Oliveira J. C., Oliveira L. C., Mathias C., Pedroso G. A., Lemos D. S., Salviano-Silva A. et al. 2018 LncRNAs in cancer: another layer of complexity. J. Gene Med. 21, e3065.

Do H. and Kim W. 2018 Roles of oncogenic long non-coding RNAs in cancer development. Genomics Inform. 16, e18.

Fatica A. and Bozzoni I. 2014 Long non-coding RNAs: new players in cell differentiation and development. Nat. Rev. Genet. 15, 7–21.

Gabory A., Jammes H. and Dandolo L. 2010 The H19 locus: role of an imprinted noncoding RNA in growth and development. BioEssays 32, 473–480.

Gong W. J., Yin J. Y., Li X. P., Fang C., Xiao D., Zhang W. et al. 2016 Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response. Tumour Biol. 37, 8349–8358.

Guo Q. Y., Wang H. and Wang Y. 2017 LncRNA H19 polymorphisms associated with the risk of OSCC in Chinese population. Eur. Rev. Med. Pharmacol. Sci. 21, 3770–3774.

Gyvyte U., Kupcinskas J., Juzenas S., Inciuraite R., Poskiene, L., Salteniene V. et al. 2018 Identification of long intergenic non-coding RNAs (lincRNAs) deregulated in gastrointestinal stromal tumors (GISTs). PLoS One 13, e0209342.

Hashemi M., Bahari G., Naderi M., Sadeghi Bojd S. and Taheri M. 2016 Association of lnc-LAMC2-1:1 rs2147578 and CASC8 rs10505477 polymorphisms with risk of childhood acute lymphoblastic leukemia. Asian Pac. J. Cancer Prev. 17, 4985–4989.

Hashemi M., Bahari G., Tabasi F., Moazeni-Roodi A. and Ghavami S. 2018 Association between rs1862513 and rs3745367 genetic polymorphisms of resistin and risk of cancer: a meta-analysis. Asian Pac. J. Cancer Prev. 19, 2709–2716.

Hassanzarei S., Hashemi M., Sattarifard H., Hashemi S. M. and Bahari G. 2017 Genetic polymorphisms in long noncoding RNA H19 are associated with breast cancer susceptibility in Iranian population. Meta Gene 14, 1–5.

He T. D., Xu D., Sui T., Zhu J. K., Wei Z. X. and Wang Y. M. 2017 Association between H19 polymorphisms and osteosarcoma risk. Eur. Rev. Med. Pharmacol. Sci. 21, 3775–3780.

Hu P. H., Qiao O., Wang J., Li J., Jin H., Li Z. L. et al. 2017 rs1859168 A $$>$$ C polymorphism regulates HOTTIP expression and reduces risk of pancreatic cancer in a Chinese population. World J. Surg. Oncol. 15, 155.

Hua Q., Lv X., Gu X., Chen Y., Chu H., Du M. et al. 2016 Genetic variants in lncRNA H19 are associated with the risk of bladder cancer in a Chinese population. Mutagenesis 31, 531–538.

Iyer M. K., Niknafs Y. S., Malik R., Singhal U., Sahu A., Hosono Y. et al. 2015 The landscape of long noncoding RNAs in the human transcriptome. Nat. Genet. 47, 199–208.

Jiang Y., Qin Z., Hu Z., Guan X., Wang Y., He Y. et al. 2012 Genetic variation in a hsa-let-7 binding site in RAD52 is associated with breast cancer susceptibility. Carcinogenesis 34, 689–693.

Jin T., Wu X., Yang H., Liu M., He Y., He X. et al. 2016 Association of the miR-17-5p variants with susceptibility to cervical cancer in a Chinese population. Oncotarget 7, 76647–76655.

Li L., Guo G., Zhang H., Zhou B., Bai L., Chen H. et al. 2018 Association between H19 SNP rs217727 and lung cancer risk in a Chinese population: a case control study. BMC Med. Genet. 19, 136.

Li S., Hua Y., Jin J., Wang H., Du M., Zhu L. et al. 2016 Association of genetic variants in lncRNA H19 with risk of colorectal cancer in a Chinese population. Oncotarget 7, 25470–25477.

Li X. F., Yin X. H., Cai J. W., Wang M. J., Zeng Y. Q., Li, M. et al. 2017a. Significant association between lncRNA H19 polymorphisms and cancer susceptibility: a meta-analysis. Oncotarget 8, 45143–45153.

Li Z., Li Y., Li Y., Ren K., Li X., Han X. et al. 2017b Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152. J. Biochem. Mol. Toxicol. 31, e21933.

Li Z. and Niu Y. 2019 Association between lncRNA H19 (rs217727, rs2735971 and rs3024270) polymorphisms and the risk of bladder cancer in Chinese population. Minerva. Urol. Nefrol. 71, 161–167.

Lichtenstein P., Holm N. V., Verkasalo P. K., Iliadou A., Kaprio J., Koskenvuo M. et al. 2000 Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78–85.

Lv Z., Xu Q. and Yuan Y. 2017 A systematic review and meta-analysis of the association between long non-coding RNA polymorphisms and cancer risk. Mutat. Res. 771, 1–14.

Matouk I. J., DeGroot N., Mezan S., Ayesh S., Abu-lail R., Hochberg A. et al. 2007 The H19 non-coding RNA is essential for human tumor growth. PLoS One 2, e845.

Moazeni-Roodi A. and Hashemi M. 2018 Association between miR-124-1 rs531564 polymorphism and risk of cancer: an updated meta-analysis of case-control studies. EXCLI J. 17, 608–619.

Quaye L., Tyrer J., Ramus S. J., Song H., Wozniak E., DiCioccio R. A. et al. 2009 Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer. PLoS One 4, e5983.

Song H., Ramus S. J., Kjaer S. K., DiCioccio R. A., Chenevix-Trench G., Pearce C. L. et al. 2009 Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum. Mol. Genet. 18, 2297–2304.

Verhaegh G. W., Verkleij L., Vermeulen S. H., den Heijer M., Witjes J. A. and Kiemeney L. A. 2008 Polymorphisms in the H19 gene and the risk of bladder cancer. Eur. Urol. 54, 1118–1126.

Wang L., Cai Y., Zhao X., Jia X., Zhang J., Liu J. et al. 2015 Down-regulated long non-coding RNA H19 inhibits carcinogenesis of renal cell carcinoma. Neoplasma 62, 412–418.

Xia T., Liao Q., Jiang X., Shao Y., Xiao B., Xi Y. et al. 2014 Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Sci. Rep. 4, 6088.

Xia Z., Yan R., Duan F., Song C., Wang P. and Wang K. 2016 Genetic polymorphisms in long noncoding RNA H19 are associated with susceptibility to breast cancer in Chinese population. Medicine (Baltimore). 95, e2771.

Xue M., Zhuo Y. and Shan B. 2017 MicroRNAs, long noncoding RNAs, and their functions in human disease. Methods Mol. Biol. 1617, 1–25.

Yang C., Tang R., Ma X., Wang Y., Luo D., Xu Z. et al. 2015 Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population. Oncotarget 6, 15311–15320.

Yang M. L., Huang Z., Wang Q., Chen H. H., Ma S. N., Wu R. et al. 2018 The association of polymorphisms in lncRNA-H19 with hepatocellular cancer risk and prognosis. Biosci. Rep. 38, BSR20171652

Yin Z., Cui Z., Li H., Li J. and Zhou B. 2018 Polymorphisms in the H19 gene and the risk of lung Cancer among female never smokers in Shenyang, China. BMC Cancer 18, 893.

Yu L. L., Chang K., Lu L. S. Zhao D., Han J., Zheng Y. R. et al. 2013 Lentivirus-mediated RNA interference targeting the H19 gene inhibits cell proliferation and apoptosis in human choriocarcinoma cell line JAR. BMC Cell Biol. 14, 26.

Yuan Z., Yu Y., Zhang B., Miao L., Wang L., Zhao K. et al. 2018 Genetic variants in lncRNA H19 are associated with the risk of oral squamous cell carcinoma in a Chinese population. Oncotarget 9, 23915.

Zhou X., Ye F., Yin C., Zhuang Y., Yue G. and Zhang G. 2015 The interaction between MiR-141 and lncRNA-H19 in regulating cell proliferation and migration in gastric cancer. Cell Physiol. Biochem. 36, 1440–1452.